Charged nutritive proteins and methods
Charged nutritive proteins are provided. In some embodiments the nutritive proteins an aqueous solubility of at least 12.5 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 50 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 100 g/L at pH 7. In some embodiments the nutritive proteins comprise at least one of a level of a) a ratio of branch chain amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of branch chain amino acid residues to total amino acid residues present in a benchmark protein; b) a ratio of leucine residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of leucine residues to total amino acid residues present in a benchmark protein; and c) a ratio of essential amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of essential amino acid residues to total amino acid residues present in a benchmark protein. Also provided are nucleic acids encoding the proteins, recombinant microorganisms that make the proteins, methods of making the proteins using recombinant microorganisms, compositions that comprise the proteins, and methods of using the proteins, among other things.
1. A liquid formulation comprising a recombinant nutritive protein wherein the nutritive protein is present at a concentration of greater than 50 g/L and in an amount of at least about 1 g, wherein the nutritive protein comprises a polypeptide sequence comprising the sequence set forth in SEQ ID NO:485, and wherein the recombinant nutritive protein is not glycosylated.
2. The formulation of claim 1 , wherein the polypeptide sequence comprises a ratio of at least one branch chain amino acid residue to total amino acid residues greater than the ratio of at least one branch chain amino acid residue to total amino acid residues present in whey protein.
3. The formulation of claim 1 , wherein the polypeptide sequence comprises a ratio of at least one essential amino acid residue to total amino acid residues greater than the ratio of at least one essential amino acid residue to total amino acid residues present in whey protein.
4. The formulation of claim 1 , wherein the polypeptide sequence comprises a ratio of isoleucine residues to total amino acid residues greater than 6.5%, a ratio of leucine residues to total amino acid residues greater than 11%, a ratio of lysine residues to total amino acid residues greater than 9.1%, a ratio of methionine residues to total amino acid residues greater than 2.1%, a ratio of phenylalanine residues to total amino acid residues greater than 3.4%, a ratio of threonine residues to total amino acid residues greater than 7.0%, a ratio of tryptophan residues to total amino acid residues greater than 1.7%, a ratio of valine residues to total amino acid residues greater than 6.2%, a ratio of histidine residues to total amino acid residues greater than 2.0%, or a combination of two or more thereof.
5. The formulation of claim 1 , further comprising a peptide, a free amino acid, a carbohydrate, a lipid, a mineral, a vitamin, or an excipient.
6. The formulation of claim 1 , wherein the nutritive protein comprises a simulated gastric digestion half-life of less than 30 minutes.
7. The formulation of claim 1 , further a second recombinant nutritive protein that is present at a concentration of greater than 50 g/L and present in an amount effective to induce at least one of a satiation response and a satiety response in a human subject to whom the formulation is administered.
8. The formulation of claim 1 , wherein the nutritive protein is present at a concentration of greater than 100 g/L.
9. The formulation of claim 5 , further comprising a peptide.
10. The formulation of claim 5 , further comprising a free amino acid.
11. The formulation of claim 5 , further comprising a carbohydrate.
12. The formulation of claim 5 , further comprising a lipid.
13. The formulation of claim 5 , further comprising a mineral.
14. The formulation of claim 5 , further comprising a vitamin.
15. The formulation of claim 5 , further comprising an excipient.
16. The formulation of claim 6 , wherein the nutritive protein comprises a simulated gastric digestion half-life of less than 20 minutes.
17. The formulation of claim 16 , wherein the nutritive protein comprises a simulated gastric digestion half-life of less than 10 minutes.
18. The formulation of claim 17 , wherein the nutritive protein comprises a simulated gastric digestion half-life of less than 5 minutes.
19. The formulation of claim 18 , wherein the nutritive protein comprises a simulated gastric digestion half-life of less than 3 minutes.
20. The formulation of claim 19 , wherein the nutritive protein comprises a simulated gastric digestion half-life of less than 2 minutes.